Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Chernew

Showing results (51-60 of 230) with videos related to

Pageof 23
Sort By:
JAMA|August 2, 2012
Potential consequences of reforming Medicare into a competitive bidding systemZirui Song, David M Cutler, Michael E Chernew
The New England Journal of Medicine|April 5, 2018
Promise and Reality of Price TransparencyAteev Mehrotra, Michael E Chernew, Anna D Sinaiko
The American Journal of Managed Care|September 27, 2012
Competitive bidding in Medicare: who benefits from competition?Zirui Song, Mary Beth Landrum, Michael E Chernew
Health Affairs (Project Hope)|June 2, 2025
Medicare Advantage Denies 17 Percent Of Initial Claims; Most Denials Are Reversed, But Provider Payouts Dip 7 PercentBoris Vabson, Andrew L Hicks, Michael E Chernew
JAMA Internal Medicine|May 28, 2024
How Should Medicare Pay for Artificial Intelligence?Anna Zink, Michael E Chernew, Hannah T Neprash
The American Journal of Managed Care|January 9, 2026
Managed care reflections: a Q&A with A. Mark Fendrick, MD, and Michael E. Chernew, PhDA Mark Fendrick, Michael E Chernew, Christina Mattina
The American Journal of Managed Care|July 19, 2022
The merits of administrative benchmarks for population-based payment programsMichael E Chernew, Jermaine Heath, J Michael McWilliams
Journal of General Internal Medicine|February 22, 2008
Impact of fixed-dose combination drugs on adherence to prescription medicationsFeng Pan, Michael E Chernew, A Mark Fendrick
Journal of Health Economics|December 7, 2013
The spillover effects of Medicare managed care: Medicare Advantage and hospital utilizationKatherine Baicker, Michael E Chernew, Jacob A Robbins
The American Journal of Managed Care|December 14, 2020
After 25 years, AJMC® looks to the future: a Q&A with Michael E. Chernew, PhD, and A. Mark Fendrick, MDMichael E Chernew, A Mark Fendrick, Allison Inserro
Pageof 23

Showing results (51-60 of 230) with videos related to

Sort By:
Pageof 23
JAMA|August 2, 2012
Potential consequences of reforming Medicare into a competitive bidding systemZirui Song, David M Cutler, Michael E Chernew
The New England Journal of Medicine|April 5, 2018
Promise and Reality of Price TransparencyAteev Mehrotra, Michael E Chernew, Anna D Sinaiko
The American Journal of Managed Care|September 27, 2012
Competitive bidding in Medicare: who benefits from competition?Zirui Song, Mary Beth Landrum, Michael E Chernew
Health Affairs (Project Hope)|June 2, 2025
Medicare Advantage Denies 17 Percent Of Initial Claims; Most Denials Are Reversed, But Provider Payouts Dip 7 PercentBoris Vabson, Andrew L Hicks, Michael E Chernew
JAMA Internal Medicine|May 28, 2024
How Should Medicare Pay for Artificial Intelligence?Anna Zink, Michael E Chernew, Hannah T Neprash
The American Journal of Managed Care|January 9, 2026
Managed care reflections: a Q&A with A. Mark Fendrick, MD, and Michael E. Chernew, PhDA Mark Fendrick, Michael E Chernew, Christina Mattina
The American Journal of Managed Care|July 19, 2022
The merits of administrative benchmarks for population-based payment programsMichael E Chernew, Jermaine Heath, J Michael McWilliams
Journal of General Internal Medicine|February 22, 2008
Impact of fixed-dose combination drugs on adherence to prescription medicationsFeng Pan, Michael E Chernew, A Mark Fendrick
Journal of Health Economics|December 7, 2013
The spillover effects of Medicare managed care: Medicare Advantage and hospital utilizationKatherine Baicker, Michael E Chernew, Jacob A Robbins
The American Journal of Managed Care|December 14, 2020
After 25 years, AJMC® looks to the future: a Q&A with Michael E. Chernew, PhD, and A. Mark Fendrick, MDMichael E Chernew, A Mark Fendrick, Allison Inserro
Pageof 23